18F-Labeled NY104
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 18F-Labeled NY104, covering 2025-04-29 to 2025-04-29. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma